Half-year report · Q2
4530.TEDINET S100WUM0
Period2025-03-01 → 2025-08-31
Filed2025-10-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥74.9bn | 2025-03-01 → 2025-08-31 | Cons. | Net sales |
| Revenue | ¥156.0bn | 2024-03-01 → 2025-02-28 | Cons. | Net sales (5-year summary) |
| Revenue | ¥75.5bn | 2024-03-01 → 2024-08-31 | Cons. | Net sales |
| Operating income | ¥8.1bn | 2025-03-01 → 2025-08-31 | Cons. | Operating income |
| Operating income | ¥9.0bn | 2024-03-01 → 2024-08-31 | Cons. | Operating income |
| Ordinary income | ¥10.1bn | 2025-03-01 → 2025-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥24.0bn | 2024-03-01 → 2025-02-28 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.8bn | 2024-03-01 → 2024-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥10.0bn | 2025-03-01 → 2025-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥13.1bn | 2024-03-01 → 2024-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥7.0bn | 2025-03-01 → 2025-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥21.8bn | 2024-03-01 → 2025-02-28 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.1bn | 2024-03-01 → 2024-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥7.2bn | 2025-03-01 → 2025-08-31 | Cons. | Profit loss |
| Net income | ¥9.4bn | 2024-03-01 → 2024-08-31 | Cons. | Profit loss |
| Total assets | ¥336.1bn | at 2025-08-31 | Cons. | Assets |
| Total assets | ¥343.1bn | at 2025-02-28 | Cons. | Assets |
| Total assets | ¥350.5bn | at 2024-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥67.5bn | at 2025-08-31 | Cons. | Liabilities |
| Total liabilities | ¥63.7bn | at 2025-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥268.6bn | at 2025-08-31 | Cons. | Net assets |
| Net assets / equity | ¥279.4bn | at 2025-02-28 | Cons. | Net assets |
| Net assets / equity | ¥275.9bn | at 2024-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥103.9bn | at 2025-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥114.5bn | at 2025-02-28 | Cons. | Cash and deposits |
| Cash & equivalents | ¥69.4bn | at 2025-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥89.8bn | at 2025-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥68.6bn | at 2024-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥66.4bn | at 2024-02-29v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥6.0bn | 2025-03-01 → 2025-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥18.8bn | 2024-03-01 → 2025-02-28 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥8.3bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥11.6bn | 2025-03-01 → 2025-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥17.6bn | 2024-03-01 → 2025-02-28 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥4.2bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥11.2bn | 2025-03-01 → 2025-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥15.8bn | 2024-03-01 → 2025-02-28 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥12.3bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥97 | 2025-03-01 → 2025-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥295.57 | 2024-03-01 → 2025-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥122.71 | 2024-03-01 → 2024-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥96.88 | 2025-03-01 → 2025-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥295.15 | 2024-03-01 → 2025-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥122.55 | 2024-03-01 → 2024-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 79.0% | at 2025-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.6% | at 2025-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.0% | at 2024-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 456
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -4398000000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -30000000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -100000000 | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | -8000000 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -158000000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YTDDuration | 3690000000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYTDDuration | 216000000 | JPY |
| Other net inv cf | Prior1YTDDuration | 22000000 | JPY |
| Other net inv cf | CurrentYTDDuration | 40000000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | 4242000000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -11568000000 | JPY |
| Increase decrease in short term loans payable fin cf | Prior1YTDDuration | － | JPY |
| Increase decrease in short term loans payable fin cf | CurrentYTDDuration | -100000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -29000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -282000000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -8902000000 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -7783000000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -3217000000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -3305000000 | JPY |
| Dividends paid to non controlling interests fin cf | Prior1YTDDuration | -131000000 | JPY |
| Dividends paid to non controlling interests fin cf | CurrentYTDDuration | -6000000 | JPY |
| Proceeds from disposal of treasury stock fin cf | Prior1YTDDuration | － | JPY |
| Proceeds from disposal of treasury stock fin cf | CurrentYTDDuration | 351000000 | JPY |
| Other net fin cf | Prior1YTDDuration | -68000000 | JPY |
| Other net fin cf | CurrentYTDDuration | -62000000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -12350000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -11188000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 2102000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | -3651000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 2251000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -20360000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 66366000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 89780000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 68617000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 69420000000 | JPY |
| Advertising expenses sga | Prior1YTDDuration | 8005000000 | JPY |
| Advertising expenses sga | CurrentYTDDuration | 7650000000 | JPY |
| Promotion expenses sga | Prior1YTDDuration | 7026000000 | JPY |
| Promotion expenses sga | CurrentYTDDuration | 6458000000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 5106000000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 6610000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2025-10-10 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第124期中(自 2025年３月１日 至 2025年８月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)久光製薬株式会社 | |
| Company name in english cover page | FilingDateInstant | HISAMITSU PHARMACEUTICAL CO.,INC. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 中 冨 一 榮 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)佐賀県鳥栖市田代大官町408番地 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |